Bortezomib‑induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production

Purpose The proteasome inhibitor bortezomib (PS-341) has displayed significant efficiency against pancreatic cancer cells. However, the underlying mechanisms are not fully understood. Here, we tested if ceramide production was involved in the bortezomib’s effect.